Search result for 'torrent pharmaceuticals'

Indian pharmaceutical stocks soared after the US exempted drugs from reciprocal tariffs. Gland Pharma and Aurobindo Pharma led the rally, gaining over 14% and 9% respectively.

Torrent Investments, a promoter entity of Torrent Pharmaceuticals, has sold a 2.9% stake in the company for Rs 3,086 crore through open market transactions. The shares were sold in the price range...

Torrent Pharmaceuticals received a demand notice of Rs 6.32 lakh from the NPPA for launching a new drug without prior price approval. The NPPA enforces drug pricing regulations in India.

Leading pharma companies like Sun Pharma and Torrent Pharma have denied manufacturing drugs flagged by CDSCO as 'not of standard quality', claiming they are counterfeits.

Torrent Pharmaceuticals received a Form 483 with one observation from the USFDA after an inspection of its Pithampur manufacturing facility. The observation is procedural in nature and the company...

Torrent Pharmaceuticals received a Form 483 with five observations from the USFDA after an inspection of its Gujarat manufacturing plant. The company will respond to the observations within the...

Torrent Pharmaceuticals has licensed Vonoprazan, a novel P-CAB for GERD treatment, from Takeda. The drug will be marketed in India under the brand name Kabvie.

Torrent Pharmaceuticals reported a 52% jump in its consolidated profit after tax to Rs 443 crore in the third quarter ended December 2023, driven by strong domestic and international growth.

USFDA issued Form 483 with 5 procedural observations to Torrent Pharma's Gujarat oral manufacturing facility. The observations were not related to data integrity.